We’re thrilled to see the BeVigilant™ OraFusion™ System featured in DSOPro as a key innovation shaping the future of DSOs. The article highlights how the BeVigilant™ OraFusion™ System enables clinicians to detect early signs of oral cancer in real-time, right from the dental chair, using a simple, noninvasive saliva sample and AI-driven biomarker analysis. It also emphasizes how seamlessly the system integrates into existing workflows, helping DSOs deliver elevated patient care while streamlining clinical decision-making.
Read the full article here.